
Protocol timeline for a pilot study of pembrolizumab immune checkpoint inhibition in combination with quad-shot radiotherapy for patients with advanced/recurrent head and neck cancer.

ICI: Immune checkpoint inhibitor; OS: Overall survival; PFS: Progression-free survival; RT: Radiotherapy.